Detailed Analysis and Radiomic Prediction of First Progression Sites of First-Line Targeted Therapy for EGFR-Mutant Lung Adenocarcinoma Patients With Systemic Metastasis

Detailed Analysis and Radiomic Prediction of First Progression Sites of First-Line Targeted Therapy for EGFR-Mutant Lung Adenocarcinoma Patients With Systemic Metastasis

BackgroundWe aimed to analyze the first progression sites of first-line tyrosine kinase inhibitor (TKI) treatment for EGFR-mutant lung adenocarcinoma patients with systemic metastasis to recognize the potential candidates who might benefit from radiotherapy and establish a radiomic-based model to pr...

Full description

Bibliographic Details
Main Authors: Xiaoyang Li, Runping Hou, Wen Yu, Xueru Zhu, Hongwei Li, Yidong Yang, Dong Qian, Xiaolong Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
stage IV lung adenocarcinoma
systemic metastasis
radiotherapy
first-line TKI
progression sites
radiomics
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.757892/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.757892/full

Similar Items